Preksha Saparia*, Akshat Patel, Heer Shah, Kirtan Solanki, Aashal Patel and Maulin Sahayata
Schizophrenia is a mental disorder characterized by disruptions in thought processes, perceptions, emotional responsiveness, and social interactions. Schizophrenia affects approx. 24 million people or 1 in 300 people (0.32%) worldwide. This rate is 1 in 222 people (0.45%) among adults. Here, a person's ability to think, feel and behave is affected. Difficulty with concentration and memory may also be present. According to neurobiological theory, schizophrenia is the result of neurotransmitter dysregulation such as: An Excess of Dopamine, Reduced Glutamate In The Cerebrospinal Fluid, Levels of Gamma-Aminobutyric Acid (Gaba) Expression In Prefrontal Cortex, Or Reduced Levels Of Serotonin Hence, one can say, Schizophrenia is the major mental illness of our time and causes serious disturbances for those with the condition as well as using up significant proportions of scarce health resources. This paper reviews the recent literature on advances in introduction, etiology, symptoms, and treatments. Methodological problems encountered in researching this condition are discussed. Advances in treatments offered for this condition have improved outcomes but whether the patient receives these treatments may depend on what local services are prepared to offer.
